The financing was led by Amzak Health, according to a Jan. 31 news release. Money will go towrd the company’s investigational device exemption 2-level clinical trial. The trial will evaluate the disc at two contiguous levels compared to anterior cervical discectomy and fusion.
Through the investment Joyce Erony of Amzak Health also joined Synergy’s board of directors.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
